ME3241
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ME3241, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ME3241 Administered Intravenously in Healthy Adult Participants [Phase 1]